Physicists Play A Hands-On Role In Super Facilities Construction

Well-rounded scientists who directly oversee the building of accelerators and reactors swap glory for grander achievements High on a ridge in Berkeley, Calif., construction workers swarm over a $100 million scientific instrument, called the Advanced Light Source, that will allow scientists to peer into living cells and photograph lightning-fast chemical reactions. A continent away, at Brookhaven National Laboratory in Upton, N.Y., bulldozers have begun chewing up the dirt for the Relativistic

Written byMarcia Clemmitt
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

High on a ridge in Berkeley, Calif., construction workers swarm over a $100 million scientific instrument, called the Advanced Light Source, that will allow scientists to peer into living cells and photograph lightning-fast chemical reactions. A continent away, at Brookhaven National Laboratory in Upton, N.Y., bulldozers have begun chewing up the dirt for the Relativistic Heavy Ion Collider, a $400 million accelerator that will give physicists a window into nuclear processes that have not occurred in the natural universe since microseconds after the Big Bang.

Similar activity is going on in Norfolk, Va., home of the $430 million Continuous Electron Beam Accelerator Facility (CEBAF); Argonne, Ill., future home of the $450 million Advanced Photon Source (APS); and Oak Ridge, Tenn., site of the $900 million Advanced Neutron Source (ANS).

Scientists expect that these massive instruments, now in various stages of development, will give them the tools to make fresh and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies